What move does the options market price into Rigel Pharmaceuticals's report?

Implied ±10.2%, either direction.

How often does Rigel Pharmaceuticals move more than the options market prices?

2 of the last 8 reports moved at least as far as the implied move.

RIGLNasdaqPharmaceutical Preparations

Rigel Pharmaceuticals Inc (RIGL) earnings date, market-implied expected move, and options open interest by expiry

51.13

+2.27 · +4.65%

Regular session15:31 ET

Open51.20Volume286,978Mkt cap$912.7MP/E2.95EPS17.36

Day49.95 – 51.3883%52-wk24.95 – 52.6195%

RIGL

Rigel Pharmaceuticals Inc

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±10.2%implied · report alone

8Q avg ±11.0%·×0.93·fair

43.8653.86

straddle ±12.5%

spot 48.86exp Nov 20ATM strike 49ATM straddle 7.20IV 86%

Nov 3 closereport share · term structure

Expected move

Inputs

Next report

Nov 5

after close · in 1 day

confirmedQ3 FY26

Calendar

Next report

Last report

+4.60%

vs ±12.9% implied · ×0.36

shaded = implied · ▲▼ = realized

Aug 4 '26 · confirmed

Implied vs realized

Largest filed tie

42.00%

of RIGL revenue · McKesson

customerRIGL 10-K

Supply chain

Largest filed tie

13F top-10 QoQ

+35.58%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

154 managers

Top fund weight

0.24%

RIGL weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Rigel Pharmaceuticals (RIGL) reports on Nov 5 after close (confirmed date).

Implied vs realized

8 reports

2 of 8≥ implied

avg implied: ±14.7%
avg realized: ±11.0%

Mar 4 '25Mar 4 '25confirmed±14.2%▼−8.11%×0.57

May 6 '25May 6 '25confirmed±12.0%▲+1.15%×0.10

Aug 5 '25Aug 5 '25confirmed±20.8%▲+22.98%×1.10

Nov 4 '25Nov 4 '25confirmed±15.3%▲+33.37%×2.18

Jan 12 '26Jan 12 '26confirmed±10.6%▼−2.15%×0.20

Q1 FY26Mar 3 '26confirmed±15.5%▼−10.27%×0.66

May 5 '26May 5 '26confirmed±16.4%▼−5.06%×0.31

Q2 FY26Aug 4 '26confirmed±12.9%▲+4.60%×0.36

quarterimplied−35%0+35%realized×

Q2 FY26±12.9%▲+4.60%×0.36

May '26±16.4%▼−5.06%×0.31

Q1 FY26±15.5%▼−10.27%×0.66

Jan '26±10.6%▼−2.15%×0.20

Nov '25±15.3%▲+33.37%×2.18

Aug '25±20.8%▲+22.98%×1.10

2 older reports

May '25±12.0%▲+1.15%×0.10

Mar '25±14.2%▼−8.11%×0.57

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Oct 30 close

0.18OI · 3 expiries · Oct 30 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

81+14%Nov 2016d446+50%

327+2%Dec 1844d0.70470−1%0.70

87+6%Mar 19135d0.30290+1%0.30

ExpiryPutsCallsP/C

Nov 2016d81+14%446+50%0.18

Dec 1844d327+2%470−1%0.70

Mar 19135d87+6%290+1%0.30

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±12.5%

Funds 4

XBI±0.0%

IWM±0.0%

UWM±0.0%

VTI±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ2 FY26

21.97%as filednet margin · revenue +33.81% QoQ · −22.60% YoY

Revenue

$79M+33.81% QoQ

Gross profit

$70M+29.45% QoQ

89.17% margin

Operating income

$24M+98.36% QoQ

29.95% margin

Pre-tax income

$24M+102.32% QoQ

Net income

$17M+99.79% QoQ

21.97% margin

Cost of revenue

$9M+85.08% QoQ

Operating expenses

$47M+10.10% QoQ

SG&A $33M

R&D $14M

Tax

$6M+109.62% QoQ

Other income

$10,000+104.39% QoQ

Revenue$79M+33.81%

Gross profit

$70M+29.45%

89.17% margin

Operating income

$24M+98.36%

29.95% margin

Pre-tax income

$24M+102.32%

Net income

$17M+99.79%

21.97% margin

Cost of revenue

$9M+85.08%

Operating expenses

$47M+10.10%

SG&A $33M

R&D $14M

Other income$10,000+104.39%

Tax$6M+109.62%

flow · deduction · inflow · signed % = QoQSource: SEC filings · standardized · QE Jun 30 '26 · width = $

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 3 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 15:30 ET

Intraday

Event sensitivity

PPI ×1.00· ±3.1% vs ±3.1% · 10 releases

eventrelease day|move|up · n×base

PPIproducer prices±3.1%6 of 10×1.00

CPIconsumer prices±2.8%3 of 10×0.89

FOMCrate decision±2.7%12 of 24×0.88

PCEpersonal income & outlays±2.0%7 of 19×0.66

GDPgross domestic product±1.9%7 of 19×0.62

NFPjobs report±1.9%5 of 10×0.60

CPROFcorporate profits±1.7%6 of 12×0.56

Bar = avg |move| to ±4% · tick = ±3.1% avg day · ×base = |move| ÷ ±3.1% · min 6 releases

Earnings history

EPS 0.88 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 4 '26 · confirmed	0.88	—
Q1 FY26	Mar 3 '26 · confirmed	0.44	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod